Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enteroendocrine K and L cells in healthy and type 2 diabetic individuals
Tina Jorsal, Nicolai A. Rhee, Jens Pedersen, et al.
Diabetologia (2017) Vol. 61, Iss. 2, pp. 284-294
Open Access | Times Cited: 145

Showing 1-25 of 145 citing articles:

Glucagon-like peptide 1 (GLP-1)
Timo D. Müller, Brian Finan, Stephen R. Bloom, et al.
Molecular Metabolism (2019) Vol. 30, pp. 72-130
Open Access | Times Cited: 1312
Glucagon-like peptide 1 in health and disease
Andreas Andersen, Asger Lund, Filip K. Knop, et al.
Nature Reviews Endocrinology (2018) Vol. 14, Iss. 7, pp. 390-403
Closed Access | Times Cited: 436
Treatment of type 2 diabetes: challenges, hopes, and anticipated successes
Michael A. Nauck, Jakob Wefers, Juris J. Meier
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 8, pp. 525-544
Closed Access | Times Cited: 203
The incretin system in healthy humans: The role of GIP and GLP-1
Jens J. Holst
Metabolism (2019) Vol. 96, pp. 46-55
Open Access | Times Cited: 183
Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals
Lærke S. Gasbjerg, Mads M. Helsted, Bolette Hartmann, et al.
Diabetes (2019) Vol. 68, Iss. 5, pp. 906-917
Open Access | Times Cited: 155
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
Tea Lund Laursen, Christoffer Hagemann, Chunshan Wei, et al.
World Journal of Hepatology (2019) Vol. 11, Iss. 2, pp. 138-149
Open Access | Times Cited: 155
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
Rola Hammoud, Daniel J. Drucker
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 4, pp. 201-216
Closed Access | Times Cited: 130
Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases
Sofie Hædersdal, Andreas Andersen, Filip K. Knop, et al.
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 6, pp. 321-335
Closed Access | Times Cited: 77
Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease
Giovanni Targher, Alessandro Mantovani, Christopher D. Byrne
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 2, pp. 179-191
Open Access | Times Cited: 74
Glucose-dependent insulinotropic polypeptide (GIP)
Timo D. Müller, Alice E. Adriaenssens, Bo Ahrén, et al.
Molecular Metabolism (2025) Vol. 95, pp. 102118-102118
Open Access | Times Cited: 2
Gut-Proglucagon-Derived Peptides Are Essential for Regulating Glucose Homeostasis in Mice
Youngmi Song, Jacqueline A. Koehler, Laurie L. Baggio, et al.
Cell Metabolism (2019) Vol. 30, Iss. 5, pp. 976-986.e3
Open Access | Times Cited: 115
Incretins in obesity and diabetes
Chee W. Chia, Josephine M. Egan
Annals of the New York Academy of Sciences (2019) Vol. 1461, Iss. 1, pp. 104-126
Open Access | Times Cited: 79
Nutrient-Induced Cellular Mechanisms of Gut Hormone Secretion
Van B. Lu, Fiona M. Gribble, Frank Reimann
Nutrients (2021) Vol. 13, Iss. 3, pp. 883-883
Open Access | Times Cited: 66
Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases
Yuan Zeng, Yifan Wu, Qian Zhang, et al.
mBio (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 32
The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide
Lærke S. Gasbjerg, Mette M. Rosenkilde, Juris J. Meier, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 11, pp. 3079-3092
Closed Access | Times Cited: 24
Prebiotics as modulators of colonic calcium and magnesium uptake
Friederike Stumpff, David Manneck
Acta Physiologica (2025) Vol. 241, Iss. 2
Open Access | Times Cited: 1
Control of insulin secretion by GLP-1
Ben Jones, Stephen R. Bloom, Teresa Buenaventura, et al.
Peptides (2018) Vol. 100, pp. 75-84
Closed Access | Times Cited: 77
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
Silvano Paternoster, Marco Falasca
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 65
Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
Geke Aline Boer, Jens J. Holst
Biology (2020) Vol. 9, Iss. 12, pp. 473-473
Open Access | Times Cited: 65
Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion
Brandon L. Panaro, Bernardo Yusta, Dianne Matthews, et al.
Molecular Metabolism (2020) Vol. 37, pp. 100990-100990
Open Access | Times Cited: 53
An overview of obesity mechanisms in humans: Endocrine regulation of food intake, eating behaviour and common determinants of body weight
Simone Theilade, Mikkel Christensen, Tina Vilsbøll, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. S1, pp. 17-35
Open Access | Times Cited: 43
Intestinal Enteroendocrine Cells: Present and Future Druggable Targets
Roger Atanga, Varsha Singh, Julie In
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8836-8836
Open Access | Times Cited: 18
Gut hormones and bone homeostasis: potential therapeutic implications
Béatrice Bouvard, Guillaume Mabilleau
Nature Reviews Endocrinology (2024)
Closed Access | Times Cited: 8
The bile–gut axis and metabolic consequences of cholecystectomy
Andreas H. Lange, Miriam G Pedersen, Anne‐Marie Ellegaard, et al.
European Journal of Endocrinology (2024) Vol. 190, Iss. 4, pp. R1-R9
Closed Access | Times Cited: 7
The aromatic amino acid sensor GPR142 controls metabolism through balanced regulation of pancreatic and gut hormones
Olga Rudenko, Jin Shang, Alexander Munk, et al.
Molecular Metabolism (2018) Vol. 19, pp. 49-64
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top